Analysis of Australian exports of Basic Pharmaceutical Products and Pharmaceutical Preparations to Egypt reveals significant trends over the past decade. The value stood at 2734.6 thousand USD in 2023. Year-on-year variation demonstrates periods of substantial growth and some declines, notably in 2017 and 2022. From 2013 to 2023, the compound annual growth rate (CAGR) reflects both robust expansion in earlier years and moderated growth in recent times.
Key observations include:
- 2022 saw a decline of 4.38% from the prior year.
- 2023 registered a 4.83% increase year-on-year.
- The 5-year CAGR leading to 2023 was 5.73%.
- Forecasts suggest a moderate growth, with a forecast 5-year CAGR of 3.03% from 2024 to 2028.
Future trends to watch for:
Market analysts should closely monitor regulatory changes in Egypt's healthcare sector and any shifts in global pharmaceutical supply chains. Additionally, currency fluctuations and economic stability in both regions may significantly impact trade dynamics.
